<DOC>
	<DOCNO>NCT02250508</DOCNO>
	<brief_summary>The main objective study - compare pharmacokinetics ( PK ) Optivate速 Haemate P速 various type vonWillebrand disease ( VWD ) use result VWF : RCo , VWF : Ag , VWF : CBA Factor VIII assay . - compare clinical tolerance safety two treatment single IV infusion subject VWD .</brief_summary>
	<brief_title>A Study Compare Pharmacokinetics Safety Optivate速 Haemate P速 Patients With Von Willebrand Disease .</brief_title>
	<detailed_description />
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Previously treat subject least 12 year age , type VWD eligible entry study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>